Trademark: 87718255
Word
TABMELT
Status
Registered
Status Code
700
Status Date
Tuesday, June 4, 2019
Serial Number
87718255
Registration Number
5771628
Registration Date
Tuesday, June 4, 2019
Mark Type
4000
Filing Date
Tuesday, December 12, 2017

Trademark Owner History
Sentar Pharmaceuticals - Original Registrant

Classifications
5 Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable tablets that facilitate the delivery of pharmaceutical preparations; Nutraceuticals for use as a dietary supplement; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the endocrine system, the digestive system, the excretory system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, the respiratory system, and/or the skeletal system; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Vaccine preparations; Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for the endocannabinoid; Human vaccine preparations; Oral vaccine preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
TAB MELT

Trademark Events
Jul 25, 2023
Withdrawal Of Attorney Granted
Jul 25, 2023
Teas Withdrawal Of Attorney Received
Jun 6, 2022
Teas Change Of Correspondence Received
Jun 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 4, 2019
Registered-Supplemental Register
Apr 30, 2019
Law Office Publication Review Completed
Apr 30, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 30, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 30, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 25, 2019
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Apr 24, 2019
Approved For Registration Supplemental Register
Apr 24, 2019
Use Amendment Accepted
Apr 19, 2019
Teas Change Of Correspondence Received
Apr 19, 2019
Teas Change Of Correspondence Received
Apr 20, 2019
Teas/Email Correspondence Entered
Apr 19, 2019
Correspondence Received In Law Office
Apr 19, 2019
Teas Response To Office Action Received
Apr 20, 2019
Amendment To Use Processing Complete
Apr 20, 2019
Use Amendment Filed
Apr 19, 2019
Teas Amendment Of Use Received
Jan 17, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 17, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 30, 2018
Notification Of Non-Final Action E-Mailed
Oct 30, 2018
Non-Final Action E-Mailed
Oct 30, 2018
Non-Final Action Written
Oct 10, 2018
Teas/Email Correspondence Entered
Oct 10, 2018
Correspondence Received In Law Office
Oct 2, 2018
Assigned To Lie
Sep 20, 2018
Teas Response To Office Action Received
Mar 22, 2018
Notification Of Non-Final Action E-Mailed
Mar 22, 2018
Non-Final Action E-Mailed
Mar 22, 2018
Non-Final Action Written
Mar 22, 2018
Assigned To Examiner
Dec 22, 2017
New Application Office Supplied Data Entered
Dec 15, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24